- CA$8.61bn
- CA$18.19bn
- CA$13.00bn
- 68
- 67
- 79
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,495 | 5,587 | 10,573 | 14,087 | 12,997 |
Cost of Revenue | |||||
Gross Profit | 2,268 | 2,409 | 2,865 | 2,949 | 2,885 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,385 | 4,728 | 9,670 | 13,155 | 11,824 |
Operating Profit | 110 | 859 | 903 | 932 | 1,173 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 813 | 699 | 446 | 716 | 912 |
Provision for Income Taxes | |||||
Net Income After Taxes | 840 | 572 | 340 | 573 | 689 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 834 | 552 | 283 | 523 | 673 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 769 | 486 | 230 | 399 | 641 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.721 | 1.21 | 0.892 | 1.42 | 1.41 |
Dividends per Share |